Scalper1 News
Questcor Pharmaceuticals (QCOR) offered a glimpse of its Q4 prescription numbers, and CEO Don Bailey said “all options are on the table” for spending the firm’s considerable cash hoard, sending shares up in the stock market today. At the JPMorgan Healthcare Conference, Bailey did not reveal any precise Q4 numbers but said paid subscriptions of its lead drug Acthar numbered around 2,500. That was roughly flat with Q3, but Bailey said one of the Scalper1 News
Scalper1 News